Abstract
Treatment of murine myoblasts, myotubes and tumour cells with a tumour-produced lipid mobilizing factor (LMF), caused a concentration-dependent stimulation of protein synthesis, within a 24 h period. There was no effect on cell number or [3H] thymidine incorporation, but a similar concentration-dependent stimulation of 2-deoxyglucose uptake. LMF produced an increase in intracellular cyclic AMP levels, which was linearly (r2= 0.973) related to the increase in protein synthesis. The effect of LMF was attenuated by the adenylate cyclase inhibitor MDL12330A, and was additive with the stimulation produced by forskolin. Both propranolol (10 μM) and the specific β3-adrenergic receptor antagonist SR 59230A (10–5M), significantly reduced the stimulation of protein synthesis induced by LMF. Protein synthesis was also increased by 69% (P = 0.006) in soleus muscles of mice administered LMF, while there was a 26% decrease in protein degradation (P = 0.03). While LMF had no effect on the lysosomal enzymes, cathepsins B and L, there was a decrease in proteasome activity, as determined both by the ‘chymotrypsin-like’ enzyme activity, as well as expression of proteasome α-type subunits, determined by Western blotting. These results show that in addition to its lipid-mobilizing activity LMF also increases protein accumulation in skeletal muscle both by an increase in protein synthesis and a decrease in protein catabolism. © 2001 Cancer Research Campaign http://www.bjcancer.com
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anderson PT, Helferich WG, Parkhill LC, Merkel RA and Bergen WG (1990) Ractopamine increases total and myofibrillar protein synthesis in cultured rat myotubes. J Nutr 120: 1677–1683
Attaix P and Taillander D (1998) The critical role of the ubiquitin-proteasome pathway in muscle wasting in comparison to lysosomal and Ca2+-dependent systems. Adv Mol Cell Biol 27: 235–266
Bell AW, Bauman DE, Beerman DH and Harrell RJ (1998) Nutrition, development and efficacy of growth modifiers in livestock species. J Nutr 128: 360S–363S
Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553–14556
de Groot RP, den Hertog J, Vandenheede JR, Goris J and Sassome-Corsi R (1993) Multiple and cooperative phosphorylation events regulate the CREM activator function. EMBO J 12: 3903–3911
Faure M, Yoyno-Yasenetskaya TA and Bourne HR (1994) cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269: 7851–7859
Frodin M, Peraldi P and Van Obberghen E (1994) Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269: 6207–6214
Grant AL, Helferich WG, Merkell RA and Bergen WG (1990) Effects of phenethanolamine and propranolol on the proliferation of cultured chick breast muscle satellite cells. J Anim Sci 68: 652–658
Groundwater P, Beck SA, Barton C, Adamson C, Ferrier IN and Tisdale MJ (1990) Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. Br J Cancer 62: 816–821
Habener JF (1990) Cyclic AMP-response element binding proteins: a cornucopia of transcription factors. Mol Endocrinol 4: 1087–1094
Hirai K, Hussey HJ, Barber MD, Price SA and Tisdale MJ (1998) Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58: 2359–2365
Khan S and Tisdale MJ (1999) Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor. Int J Cancer 80: 444–447
Kimball SR, Horetsky RL and Jefferson LS (1998) Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. Am J Physiol 274: C221–C228
Li J and Adrian TE (1999) A factor from pancreatic and colon cancer cells stimulates glucose uptake and lactate production in myoblasts. Biochem Biophys Res Commun 260: 626–633
Lorite MJ, Cariuk P and Tisdale MJ (1997) Induction of muscle protein degradation by a tumour factor. Br J Cancer 76: 1035–1040
Lorite MJ, Thompson MG, Drake JL, Carling G and Tisdale MJ (1998) Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 78: 850–856
Mersmann HJ (1998) Overview of the effects of β-adrenergic receptor agonists on animal growth including mechanisms of action. J Anim Sci 76: 160–172
McMillan DN, Noble BS and Maltin CA (1992) The effect of the β-adrenergic agonist clenbuterol on growth and protein metabolism in rat muscle cell cultures. J Anim Sci 70: 3014–3023
Nisoli E, Tonello C, Landi M and Carruba MO (1996) Functional studies of the first selective β3-adrenergic receptor antagonist SR59230A in rat brown adipocytes. Mol Pharm 49: 7–14
Orino E, Tanaka K, Tamura T, Sone S, Ogura T and Ichihara A (1991) ATP-dependent reversible association of proteasomes with multiple protein components to form 26S complexes that degrade ubiquitinated proteins in human HL-60 cells. FEBS Lett 284: 206–210
Smith KL and Tisdale MJ (1993) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680–685
Southorn BG and Palmer RM (1990) Inhibitors of phospholipase A2block the stimulation of protein synthesis by insulin in L6 myoblasts. Biochem J 270: 737–739
Stefanovic D, Erickson E, Pike LJ and Maller JL (1986) Activation of a ribosomal protein S6 protein kinase in xenopus oocytes by insulin and insulin-receptor kinase. EMBO J 5: 157–160
Sturgill TW and Wu J (1991) Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6. Biochim Biophys Acta 1092: 350–357
Tisdale MJ (1997) Biology of cachexia. J Natl Cancer Inst 89: 1763–1773
Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K and Tisdale M (1996) Characterization of a cancer cachectic factor. Nature 379: 739–742
Waalkes TP and Udenfriend SA (1957) A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 50: 733–736
Wettenhall REH and Cohen P (1982) Isolation and characterisation of cyclic AMP-dependent phosphorylation sites from rat liver ribosomal protein S6. FEBS Lett 140: 263–269
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Islam-Ali, B., Tisdale, M. Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation. Br J Cancer 84, 1648–1655 (2001). https://doi.org/10.1054/bjoc.2001.1834
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1834
Keywords
This article is cited by
-
Cancer cachexia: impact, mechanisms and emerging treatments
Journal of Cachexia, Sarcopenia and Muscle (2013)
-
Cancer cachexia as a model for treatment of obesity
International Journal of Diabetes in Developing Countries (2012)
-
Entropy production in a cell and reversal of entropy flow as an anticancer therapy
Frontiers of Physics in China (2009)
-
Physicochemical attack against solid tumors based on the reversal of direction of entropy flow: an attempt to introduce thermodynamics in anticancer therapy
Diagnostic Pathology (2006)
-
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo
British Journal of Cancer (2002)
